Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bausch & Lomb (BLCO) Cash & Equivalents (2021 - 2025)

Historic Cash & Equivalents for Bausch & Lomb (BLCO) over the last 5 years, with Q3 2025 value amounting to $310.0 million.

  • Bausch & Lomb's Cash & Equivalents fell 577.51% to $310.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $310.0 million, marking a year-over-year decrease of 577.51%. This contributed to the annual value of $305.0 million for FY2024, which is 785.5% down from last year.
  • Latest data reveals that Bausch & Lomb reported Cash & Equivalents of $310.0 million as of Q3 2025, which was down 577.51% from $266.0 million recorded in Q2 2025.
  • Bausch & Lomb's Cash & Equivalents' 5-year high stood at $437.0 million during Q2 2022, with a 5-year trough of $174.0 million in Q4 2021.
  • Moreover, its 5-year median value for Cash & Equivalents was $312.5 million (2024), whereas its average is $304.4 million.
  • Per our database at Business Quant, Bausch & Lomb's Cash & Equivalents surged by 10344.83% in 2022 and then crashed by 3587.3% in 2025.
  • Quarter analysis of 5 years shows Bausch & Lomb's Cash & Equivalents stood at $174.0 million in 2021, then skyrocketed by 103.45% to $354.0 million in 2022, then fell by 6.5% to $331.0 million in 2023, then fell by 7.85% to $305.0 million in 2024, then rose by 1.64% to $310.0 million in 2025.
  • Its Cash & Equivalents was $310.0 million in Q3 2025, compared to $266.0 million in Q2 2025 and $202.0 million in Q1 2025.